AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V952. A total of 4 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $638,694 | -76.1% | 82,200 | -70.2% | 0.00% | -100.0% |
| Q2 2023 | $2,671,680 | +167.6% | 276,000 | +203.0% | 0.00% | – |
| Q1 2023 | $998,456 | +1163.0% | 91,100 | +397.8% | 0.00% | – |
| Q4 2022 | $79,056 | -95.5% | 18,300 | -92.2% | 0.00% | -100.0% |
| Q3 2022 | $1,758,000 | -4.7% | 233,800 | +27.3% | 0.00% | 0.0% |
| Q2 2022 | $1,845,000 | – | 183,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 103,100 | $445,392 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 18,300 | $79,056 | 0.00% |
| SIMPLEX TRADING, LLC | 72,300 | $312 | 0.00% |